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There has been increased focus on clinically managing multi-morbidity in the older
population, but it can be challenging to find appropriate paradigm that addresses
the socio-economic burden and risk for polypharmacy. The Commission on Social
Determinants of Health (CSDH) has examined the need for institutional change and the
parallel need to address the social causes of poor health. This study explored three
potential interventions namely, meaningful information from electronic health records
(EHR), social prescribing, and redistributive welfare policies from a person-centered
perspective using the CARE (connecting, assessing, responding, and empowering)
approach. Economic instruments that immediately redistribute state welfare and reduce
income disparity such as direct taxation and conditional cash transfers could be adopted
to enable older people with long-term conditions have access to healthcare services.
Decreased socioeconomic inequality and unorthodox prescriptive interventions that
reduce polypharmacy could mitigate barriers to effectively manage the complexities
of multi-morbidity.
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INTRODUCTION
The termmulti-morbidity describes the presence of more than two long-term conditions within an
individual (1, 2). Although the term is used inconsistently and interchangeably with co-morbidity,
it is different from co-morbidity, which is the concurrent presence of two long-term conditions that
may occur before or after the onset of a disease of interest (3). Multi-morbidity is a complicated and
socially patterned phenomenon associated with socio-economic deprivation (1), because people
with multi-morbidity usually face social, mental, and physical health conditions that require care
from multiple services, and are often in need of support for additional unplanned emergency
care, which makes coordinating their care challenging (2, 4). While some people with complex
conditions might require a tailored approach such as implementing an individualized management
plan, reviewing medicines, establishing treatment burden, and other recommendations in the
NICE guidelines, this may not be beneficial for others with related and well-controlled long-term
conditions (4). A lack of understanding of the complexities of multi-morbidity, which is often
impacted by social factors that affect treatment and improved patient experience, complicates
healthcare interventions for people with the condition (5, 6).
It is estimated that one in three adults globally has multiple morbid conditions (7). In Scotland
for example, it was reported that older people (>65+ years) are living with three or more long-term
conditions, and predictions indicate that in 20 years there will be an increase of ∼50%, which will
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invariably lead to increased demand for social and health care
services (8). This implies that more funding for social and health
care services will be needed to respond to trends in the population
demographic profile due to an increase in older populations and
socioeconomic inequality (8, 9).
Socio-economic inequality is a challenge that complicates
the management of multi-morbidity among older people due
to the high cost of health care, and the disparity in income
distribution for less affluent older people in both developed and
developing countries (10). In the US, for example, the poverty
rate among older people aged 65 and over is 9.7% (11), and about
7 million older adults are living below the national poverty line
(10). Economically, poor older populations experience unequal
access to health care due to their social-economic position.
Apart from the socio-economic problems faced by less affluent
older people with multi-morbidity, healthcare providers spend
huge sums of money annually managing patients with multi-
morbidity (12) compared to those without a long-term condition
(13). For example, in Singapore, the annual economic cost of
managing an additional long-term condition is increased by
SGD$3,177 and SGD$2,265 for social and health care respectively
(14). This continuous spending on patients with multi-morbidity
is unsustainable (15); and there is a need for a more holistic
approach to the complexities of multi-morbidity (16). Scientific
attention has been drawn to the fact that, apart from the
differences in health conditions between the affluent and the less
affluent in society, the social determinants of health (sensitivity
of one’s health to the social environment) is an important area for
understanding the complexities of multi-morbidities (16).
According to the WHO (16), socioeconomic factors are a
determinant of good health throughout life. Older people who
are economically poor and isolated are more likely to have long-
term diseases and higher levels of disability, especially when they
do not receive social care that meet their needs (17). This is
especially true because socioeconomic inequality could lead to
social isolation (18) and as social beings that live in a society,
we need friends, social connections, and meaningful work, to
feel appreciated and valued. Without socioeconomic protection,
older individuals become susceptible to depression and other
physical and mental health conditions (16) and the severity of
these conditions are also connected to social status (19).
The challenges around clinical management models, socio-
economic status, and the healthcare burden arising from multi-
morbidity and increased risk of adverse drug reactions (ADR)
are continually emerging topics of discussion among healthcare
providers and policymakers (5). The onset of multi-morbidity is
present in about 98% of older population (20), who often need
treatment with multiple medications specific to the disease, pre-
disposing them to the risk of polypharmacy, which is the use of
medications not clinically indicated. This further increases the
complexity of managing multi-morbidity for both physicians and
patients (1, 21, 22).
This paper studies the complexity of multi-morbidity
among older people (≥65 years) in relation to socio-economic
status and polypharmacy. It examines the influence of socio-
economic inequalities, drawing from the Commission on
Social Determinants of Health (CSDH), a global network
brought together by the WHO that aims to address the
social causes of poor health and health inequity by inspiring
policy and institutional change (23). The CSDH framework
shows how socio-economic and political mechanisms such
as income, housing, education, and employment gives rise
to economically stratified populations, which in turn, shapes
health determinant status and differences in vulnerability to
morbid conditions (24, 25). These factors play a role in
shaping the lives of older people and can determine the extent
to which the complexities of multi-morbidity are managed
(25). The study proposes implementing redistributive welfare
policies or social program that reallocate wealth to citizens
in order to reduce socioeconomic inequalities. The use of
information from electronic health records and social prescribing
to prevent unnecessary drug prescription were two other
suggested interventions discussed using the CARE approach (26,
27). The CARE approach is an important framework for person-
centered and empathic encounters in healthcare relationships.
It is used to understand a patient’s situation, perspective, and
underlying meanings, and to communicate this accurately in a
flexible and helpful way (27). It involves actively engaging with
a patient to open communication lines (connecting), listening
for attached meanings (accessing), accurately communicating
this understanding (responding), and planning measures in
partnership with them (empowering) (27). The flexibility offered
by this approach allows for different guiding principles to be
applied to different circumstances.
This paper will be organized first by highlighting the
complexities of multi-morbidity in relation to polypharmacy
and socio-economic status. Next, person-centered interventions
namely, social-prescribing, electronic health records, and models
for effective communication between patients and healthcare
providers will be presented using the CARE approach. The study
will discuss ways society can redistribute welfare so that income
disparity is reduced, and will conclude with a summary of how
older people may benefit from the interventions.
THE COMPLEXITIES OF
MULTI-MORBIDITY IN THE OLDER
PERSON
Most people above 65 years of age live with multi-morbid
conditions (28), and no established index exists for measuring
the complexity of multi-morbidity based on socio-economic
indicators (29). Some studies have attempted to develop
instruments tomeasure the condition (30) by reviewingmeasures
used in primary and community care settings. As Huntley
et al. (31) reiterated, the lack of standardized indicators
for accessing and measuring multi-morbidity are due to its
complex nature.
Multi-morbidity among older people is associated with the
risk of ADR arising from multiple drug combinations which are
unnecessary and preventable, and from drug-disease interactions
(32, 33). Budnitz et al. (34) reported that ADR was common
in one-third of emergency visits by older adults. This correlates
with a previous report by Goldberg et al. (35) who stated
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that patients who took two drugs at the same time were
found to have a 13% risk of ADR, while those who took
four, seven, or more medications simultaneously were 38% and
82% at risk, respectively. Polypharmacy may arise from self-
prescription due to lack of affordable healthcare, and from
multiple treatments for poorly managed pain in older adults with
long-term conditions such as musculoskeletal diseases, cancer,
insomnia, and depression (36, 37). One study reported that 60–
75% of older people aged 65 years have persistent pain, and 80%
of this population experience pain resulting from osteoarthritis,
while ∼25–50% of older people experience significant levels of
pain from cancer (28, 38, 39). Moreover, these older patients
are usually on high doses of pain medication and frequently
seek multidisciplinary pain management services that could leave
them being administered multiple drugs in a bid to manage
chronic pain, thus increasing the risk of polypharmacy (40).
In addition to chronic pain caused by multiple diseases,
sustained lower levels of social interaction have been suggested
to contribute to depression, impaired function, and pain in older
people because of a lack of social support which is known to
have a buffering effect on pain. It is therefore important to
also understand multi-morbidity within a social context (41).
Increased interaction and togetherness between an older person
and family or neighbors, rather than with formal services is
suggested to be an important aspect of pain management that
potentially lowers the risk of polypharmacy (42). This is because
the social connections one has can provide emotional support
that helps reduce psychological distress experienced as a result
of failing health and insufficient income.
The prevalence of multi-morbidity has been associated with
inequality in income across population groups, leading to a
situation where affluent groups have the socio-economic and
political mechanisms to afford medical care, making their care
coordination less complex compared to less affluent groups,
stratified according to income, education, occupation, gender,
and race (43). These health determining social factors are
associated with the presence of multiple long-term conditions
(44) and governed by fundamental structural mechanisms such
as the presence or absence of good governance, redistributive
state welfare policies or social welfare programs, and educational
attainment, all of which shape social hierarchies and are some
of the root causes of health inequities and exclusion that make
access to health care services difficult for people with lower
socioeconomic status (44, 45).
Socioeconomic inequalities are not necessarily solely related
to health care systems. Although health inequalities may very
well amplify social inequalities, Mackenbach (46) stated that
the relationship between health inequalities and socioeconomic
inequality is probably more than a consequence of social
inequality, as health inequalities have persisted and widened
even in welfare states with generous arrangements. While Kohler
(45) highlighted a positive correlation between higher GDP
and lower socio-economic inequality, more studies are still
required to establish this relationship. The non-elimination of
the inability to access welfare resources and homogeneity of
lower socio-economic groups in association with ill-health were
two of the three circumstances suggested as plausible reasons
that health inequalities have persisted in states with generous
welfare arrangements (47). Another report discussed how a
global within-country increase in unequal income over the past
three decades was due to a decline in redistributive policies (45).
While income-generating assets are important in determining
income inequality, the non-effective implementation of welfare
redistribution leads to a suboptimal outcome (47). This clarifies
the intertwined and distinct relationship between socioeconomic
inequalities, health inequalities, a welfare state, and access to
health care systems.
A complexity survey by primary care physicians in Scotland
rated socioeconomic and behavioral factors, rather than medical
diagnosis as the major driving factors of complexity for patients
(48). In addition, a study by Barnett et al. (43) using clinical data
from registered patients in 314 medical practices in Scotland,
revealed that less affluent people living in deprived areas
were more likely to be diagnosed with long-term obstructive
pulmonary disease, depression, and pain disorders. This implies
that multi-morbidity in older individuals is potentially worsened
by one’s socio-economic potential to afford treatment for current
co-morbid conditions. Moreover, the expensive cost of treatment
from unplanned care andmedication can force people with lower
socioeconomic status further into poverty (5).
Taking care of people with multi-morbid condition cost
billions of dollars annually. A study estimating the economic cost
of multimorbidity among older people in Singapore found that
about SGD$15,148 was the total annual societal cost required to
take care of an older person with multiple long-term condition
as opposed to SGD$5,610 for an older person with one long-
term condition and SGD$2,265 for those with no long-term
condition (14). The overall population cost was estimated at
SGD$4.37 billion and was driven by the cost for social care
rather than healthcare costs (14). This finding implies a linear
relationship between the number of long-term conditions and
increased health care expenditure. It is supported by Lehnert et al.
(49) and also by Asmus-Szepesi et al. (50) who have reported
a mean formal and informal healthcare costs of e30k euro per
older person per year in the Netherlands. The calculated informal
healthcare costs between hospital discharge and a year follow-
up was e9,5k (50), showing that the cost of unpaid caregiving
is substantial. The same can be seen in the United States where
the estimated cost of unpaid caregiving for people with dementia
is between $159–215 billion (51, 52).
HOW SOCIETY CAN REDISTRIBUTE
WELFARE SO THAT INCOME DISPARITIES
ARE REDUCED
Redistributive policies are a vital tool for decreasing
socioeconomic inequity, however, this cannot be achieved
under a model that ultimately uses private investment-led
economic growth as a criterion of progress, but instead, one
that acknowledges the firm placement of the economy in society
to maximize human well-being (53, 54). Measures to reduce
socio-economic inequalities should incorporate asset/wealth
inequality and not only economic metrics to optimize inequality
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reduction; this involves the equitable distribution of assets
between the public and private sectors (45). Addressing
equitable redistribution of wealth, affordable social care and
health care among older individuals will help mitigate the
complexity inherent in managing multi-morbidity in the older
population (23).
Although there is no easy solution to effectively reduce
income disparities, shifting resources from the affluent to those
at the bottom of the income scale through taxation is one
way to give older people with long-term conditions access to
health care, and the most direct and immediate way to reduce
inequality and social tensions (55). Apart from progressive
taxation, increasing opportunities for growth and cash transfers
are other instruments that can be implemented to keep inequality
in check (55). Cash transfer programs that give older adults
with multi-morbidity access to healthcare on the condition that
they adhere to medical treatment and maintain contact with
healthcare services are practical approaches to sustaining welfare
redistribution. Examples of conditional cash transfers include
those that require regular school attendance for children in
developing economies and other cash transfer initiatives such
as Mexico’s Prospera and Brazil’s Bolsa Família, which have
been successful (55). Conditional cash transfers in the form of
micro-credits, transportation, education, and training for carers
are measures that can directly impact on the quality of life for
the older person, assisting them in coping with adverse shocks
pertaining to their circumstance. While income taxation and
redistribution is a direct way to reduce inequality, it is, however, a
short term measure with less future growth; indirect taxation on
the other hand may not close the inequality gap in the short term
but could lead to future growth unlike subsidies on consumption
which do not effectively redistribute wealth, because the affluent
also enjoy these measures (55, 56).
INTERVENTION FOR POLYPHARMACY
USING A PERSON-CENTERED APPROACH
Multi-morbid disease management templates that take into
account factors such as polypharmacy and social exclusion are a
way to connect with, access, respond, and empower older people,
using the CARE approach to communicate and develop policies
that provide direction for patient pathways and guidelines in the
management of multi-morbid conditions (57). Encounters that
promote social prescribing have been touted as an alternative
that could reduce polypharmacy, and manage the complexity
of multi-morbidity because it is a way of referring frail older
adults to healthcare services or to community support groups for
practical social support (33). This approach provides a range of
unorthodox prescriptive interventions that can be implemented
alongside primary care to optimize functioning and reduce
unnecessary prescription of medications by involving older
persons in participatory activities such as volunteering, music,
and exercise to foster togetherness within their social circles.
The use of electronic health records (EHR) is another
person-centered approach to reduce the risk associated with
polypharmacy. The Electronic Frailty Index (eFI) can be used
to foretell adverse events for older patients (58) because it
can facilitate a regular comprehensive review of prescriptions
frommultiple service providers. An accessible electronic medical
database would assist physicians in prescribing new drugs,
reviewing medication efficacy, and to deprescribe when co-
morbid conditions improve (32, 33). This method can potentially
prevent avoidable ADR that may result from polypharmacy
via drug-drug interactions. Another important aspect of the
electronic medical record system is that it contains the results of
the administrative and clinical encounters of a patient, therefore
EHR interoperability with other provider systems will help
prevent extended hospitalization and delayed referrals for older
persons due to the compilation of medical history (59). Easy
referrals and lack of extended hospitalization reduce the risk of
polypharmacy because a reduction in time spent in hospital care
reduces further drug prescriptions (60).
Research has shown that patients prioritize empathy and
the human aspects of care in clinical and disease management
(57). Developing patient pathways from a more patient-centered
approach rather than using a disease-specific model in multi-
morbid disease management for older patients have been
suggested as a way of looking to the future (61). One way
to do this is to strengthen effective communication channels
between healthcare professionals and older patients to provide
opportunities for the patient to express their views and to
participate willingly in the medical decision-making process (57).
A practical approach to establishing rapport is the self-awareness
of healthcare practitioners in how they approach the patient at
the bedside, the non-verbal way they introduce themselves, their
opening words and sentences as opposed to maintaining less
eye contact, talking loudly, raising an eyebrow which are non-
verbal communications that may come across as critical (27).
Listening more to the patient, summarizing key points of the
patient’s explanation, revising decisions about the next actions,
telling the patient what they are typing in the computer, talking
less, signaling with occasional grunts, and helping the patient
gain control in situations that require lifestyle changes rather
than additional prescription are ways of connecting, accessing
and responding to effectively communicate in a helpful and
non-patronizing way (27).
The need for effective communication between healthcare
providers and older people with multimorbidity is vital for
achieving person-centered care and lowering the treatment
burden. A report by the NHS (62) outlined that about
70–80% of the population in Scotland with long term
conditions are on self-care management due to a lack of
effective communication, because nurses in community
practice consistently overestimate or underestimate the
degree of pain in older adults, and are more likely to
perceive them as exaggerating (63). Effective communication
between healthcare professionals and the older person with
multimorbidity is crucial to gain an understanding of the patient’s
situation and enable proper diagnosis and administration
of treatment.
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CONCLUSION
Multi-morbidity in older people requires a systematic
understanding of its varied complexities in order to inform
strategies that equip healthcare practitioners with the right skill-
sets to understand the condition and to develop a standardized
assessment and treatment tool for providing care for patients
with long term conditions. Communication from a person-
centered perspective is key to encourage patient interaction and
collaboration, and to give clinicians more information that will
help them make informed medical decisions to optimize an
all-round benefit for the older person with multi-morbidity.
Reducing social and health inequities and redistributing
state wealth via direct taxation and conditional cash transfers
are important ways countries can quickly mitigate barriers
to effectively manage the complexities of multi-morbidity. In
addition, the use of electronic health records and the electronic
frailty index (EFI) are digital formats that may assist in
reducing complications arising from delayed referrals, extended
hospitalization, and for providing information on polypharmacy
and additional long-term conditions not clearly known. Since
polypharmacy is a risk factor for poor health outcomes and
mortality, social prescribing can be used as a person-centered
alternative intervention to reduce the need for additional drug
prescriptions, foster social connectedness, and reduce social
exclusion among older people with multi-morbidity.
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